- Home
- PRCH vs TVTX Comparison
PRCH vs TVTX Comparison
Compare PRCH & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- TVTX
- Stock Information
- Founded
- PRCH 2012
- TVTX 2008
- Country
- PRCH United States
- TVTX United States
- Employees
- PRCH N/A
- TVTX N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRCH Technology
- TVTX Health Care
- Exchange
- PRCH Nasdaq
- TVTX Nasdaq
- Market Cap
- PRCH 1.3B
- TVTX 1.4B
- IPO Year
- PRCH N/A
- TVTX N/A
- Fundamental
- Price
- PRCH $12.30
- TVTX $15.63
- Analyst Decision
- PRCH Strong Buy
- TVTX Strong Buy
- Analyst Count
- PRCH 8
- TVTX 16
- Target Price
- PRCH $10.91
- TVTX $33.33
- AVG Volume (30 Days)
- PRCH 1.7M
- TVTX 1.2M
- Earning Date
- PRCH 08-05-2025
- TVTX 08-06-2025
- Dividend Yield
- PRCH N/A
- TVTX N/A
- EPS Growth
- PRCH N/A
- TVTX N/A
- EPS
- PRCH N/A
- TVTX N/A
- Revenue
- PRCH $427,150,000.00
- TVTX $273,533,000.00
- Revenue This Year
- PRCH N/A
- TVTX $71.61
- Revenue Next Year
- PRCH $14.98
- TVTX $43.45
- P/E Ratio
- PRCH N/A
- TVTX N/A
- Revenue Growth
- PRCH N/A
- TVTX 75.65
- 52 Week Low
- PRCH $1.05
- TVTX $7.93
- 52 Week High
- PRCH $14.34
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- PRCH 47.97
- TVTX 49.00
- Support Level
- PRCH $12.58
- TVTX $15.28
- Resistance Level
- PRCH $13.31
- TVTX $15.97
- Average True Range (ATR)
- PRCH 0.71
- TVTX 0.62
- MACD
- PRCH -0.20
- TVTX -0.06
- Stochastic Oscillator
- PRCH 21.54
- TVTX 28.78
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.